142
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Aripiprazole for the treatment of psychotic symptoms in patients with dementia with Lewy bodies: a case series

&
Pages 543-547 | Published online: 22 Feb 2019

References

  • MckeithIGGalaskoDKosakaKConsensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International workshopNeurology1996475111311248909416
  • AarslandDRongveANoreSPFrequency and case identification of dementia with Lewy bodies using the revised consensus criteriaDement Geriatr Cogn Disord200826544545218974647
  • MoriEIkedaMKosakaKSInvestigators D-DLBS, Donepezil-DLB Study InvestigatorsDonepezil for dementia with Lewy bodies: a randomized, placebo-controlled trialAnn Neurol2012721415222829268
  • KohenILesterPELamSAntipsychotic treatments for the elderly: efficacy and safety of aripiprazoleNeuropsychiatr Dis Treat20106475820361061
  • DeleonAPatelNCCrismonMLAripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerabilityClin Ther200426564966615220010
  • BurrisKDMolskiTFXuCAripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptorsJ Pharmacol Exp Ther2002302138138912065741
  • MintzerJETuneLEBrederCDAripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed dosesAm J Geriatr Psychiatry2007151191893117974864
  • LeeHCooneyJMLawlorBAThe use of risperidone, an atypical neuroleptic, in Lewy body diseaseInt J Geriatr Psychiatry199495415417
  • AllenRLWalkerZD’AthPJKatonaCLRisperidone for psychotic and behavioural symptoms in Lewy body dementiaLancet199534689681857541499
  • TakahashiHYoshidaKSugitaTHiguchiHShimizuTQuetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case seriesProg Neuropsychopharmacol Biol Psychiatry200327354955312691793
  • LanctôtKLHerrmannNDonepezil for behavioural disorders associated with Lewy bodies: a case seriesInt J Geriatr Psychiatry200015433834510767734
  • MarderSRMcquadeRDStockEAripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trialsSchizophr Res2003612–312313612729864
  • FernandezHHTrieschmannMEFriedmanJHAripiprazole for drug-induced psychosis in Parkinson disease: preliminary experienceClin Neuropharmacol20042714515090928
  • De DeynPJesteDVSwaninkRAripiprazole for the treatment of psychosis in patients with Alzheimer’s disease: a randomized, placebo-controlled studyJ Clin Psychopharmacol200525546346716160622
  • StreimJEPorsteinssonAPBrederCDA randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer diseaseAm J Geriatr Psychiatry200816753755018591574
  • MucciAPiegariGGalderisiSCognitive-enhancing effects of aripiprazole: a case reportClin Pract Epidemiol Ment Health2008412418959801
  • KimSWShinISKimJMEffectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophreniaClin Neuropharmacol200932524324919620849
  • RiedelMSpellmannISchennach-WolffREffect of aripiprazole on cognition in the treatment of patients with schizophreniaPharmacopsychiatry2010432505720336597
  • SuzukiHGenKInoueYAn unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophreniaProg Neuropsychopharmacol Biol Psychiatry201135116116821047544